TR201821107A2 - RİVAROKSABAN İÇEREN BİR KATI FARMASÖTİK BİLEŞİM ve BİLEŞİMİN HAZIRLANIŞI YÖNTEMİ - Google Patents
RİVAROKSABAN İÇEREN BİR KATI FARMASÖTİK BİLEŞİM ve BİLEŞİMİN HAZIRLANIŞI YÖNTEMİ Download PDFInfo
- Publication number
- TR201821107A2 TR201821107A2 TR2018/21107A TR201821107A TR201821107A2 TR 201821107 A2 TR201821107 A2 TR 201821107A2 TR 2018/21107 A TR2018/21107 A TR 2018/21107A TR 201821107 A TR201821107 A TR 201821107A TR 201821107 A2 TR201821107 A2 TR 201821107A2
- Authority
- TR
- Turkey
- Prior art keywords
- preparing
- solid pharmaceutical
- pharmaceutical composition
- composition containing
- composition
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- KGFYHTZWPPHNLQ-AWEZNQCLSA-N rivaroxaban Chemical compound S1C(Cl)=CC=C1C(=O)NC[C@@H]1OC(=O)N(C=2C=CC(=CC=2)N2C(COCC2)=O)C1 KGFYHTZWPPHNLQ-AWEZNQCLSA-N 0.000 title abstract 2
- 229960001148 rivaroxaban Drugs 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000007787 solid Substances 0.000 title 1
- 238000007907 direct compression Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Mevcut buluş direk baskı yöntemi kullanılarak rivaroksaban içeren tabletlerin üretimi ve hazırlanışı ile ilgilidir
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17020596.7A EP3505160A1 (en) | 2017-12-31 | 2017-12-31 | Preparation of a solid pharmaceutical composition comprising rivaroxaban and production thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201821107A2 true TR201821107A2 (tr) | 2019-07-22 |
Family
ID=61258111
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2018/21107A TR201821107A2 (tr) | 2017-12-31 | 2018-12-29 | RİVAROKSABAN İÇEREN BİR KATI FARMASÖTİK BİLEŞİM ve BİLEŞİMİN HAZIRLANIŞI YÖNTEMİ |
Country Status (2)
| Country | Link |
|---|---|
| EP (2) | EP4257136A3 (tr) |
| TR (1) | TR201821107A2 (tr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114767647B (zh) * | 2022-03-22 | 2024-04-16 | 新发药业有限公司 | 一种利伐沙班口服固体制剂的制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19962924A1 (de) | 1999-12-24 | 2001-07-05 | Bayer Ag | Substituierte Oxazolidinone und ihre Verwendung |
| DE10355461A1 (de) | 2003-11-27 | 2005-06-23 | Bayer Healthcare Ag | Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung |
| CN102105138A (zh) | 2008-07-08 | 2011-06-22 | 德国通益药业有限公司 | 包含5-氯-n-({(5s)-2-氧代-3-[4-(3-氧代-4-吗啉基)-苯基]-1,3-噁唑烷-5-基}-甲基)-2-噻吩羧酰胺的药物组合物 |
| WO2010146179A2 (en) | 2009-06-18 | 2010-12-23 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Solid pharmaceutical composition comprising rivaroxaban |
| EP2266541A1 (en) * | 2009-06-18 | 2010-12-29 | Krka Tovarna Zdravil, D.D., Novo Mesto | Solid pharmaceutical composition comprising rivaroxaban |
| US20120231076A1 (en) | 2009-10-06 | 2012-09-13 | Ratiopharm Gmbh | Pharmaceutical compositions comprising rivaroxaban |
| EP2808011A1 (en) | 2013-05-29 | 2014-12-03 | Sandoz Ag | Process for the preparation of a pharmaceutical composition comprising Rivaroxaban |
| WO2016166733A1 (en) | 2015-04-17 | 2016-10-20 | Micro Labs Limited | A process for preparing a pharmaceutical composition comprising rivaroxaban |
| US20180214453A1 (en) * | 2015-08-05 | 2018-08-02 | Interquim, S.A. | Rivaroxaban pharmaceutical compositions |
-
2017
- 2017-12-31 EP EP23189126.8A patent/EP4257136A3/en active Pending
- 2017-12-31 EP EP17020596.7A patent/EP3505160A1/en not_active Withdrawn
-
2018
- 2018-12-29 TR TR2018/21107A patent/TR201821107A2/tr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP4257136A2 (en) | 2023-10-11 |
| EP4257136A3 (en) | 2023-11-29 |
| EP3505160A1 (en) | 2019-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201391318A1 (ru) | Твердые формы 3-(5-амино-2-метил-4-оксо-4н-хиназолин-3-ил)пиперидин-2,6-диона и их фармацевтические композиции и применение | |
| EA201891336A1 (ru) | Гетероарилгидроксипиримидиноны в качестве агонистов рецептора apj | |
| MX2019015744A (es) | Composiciones farmaceuticas. | |
| BR112014024903A2 (pt) | anticorpos biespecíficos contra tweak humanao e il17 humana e seus usos | |
| EA201690246A1 (ru) | Ингибиторы аутотаксинов, содержащие ядро гетероароматическое кольцо-бензил-амидный цикл | |
| EA201591728A1 (ru) | Гетероциклические соединения и способы их применения | |
| TR201821116A2 (tr) | POSAKONAZOL İÇEREN FARMASÖTİK BİLEŞİMLER ve ÜRETİM YÖNTEMİ | |
| EA202091397A1 (ru) | Бензохинолоновые ингибиторы vmat2 | |
| EA201600124A1 (ru) | Новые индолизиновые соединения, способ их получения и фармацевтические композиции, содержащие их | |
| EA201790650A1 (ru) | Лекарственная форма и способы применения абиратерона ацетата | |
| PH12016501686A1 (en) | Pharmaceutical compositions of sitagliptin | |
| UA116889C2 (uk) | Фармацевтична композиція, що містить суміш ізоформ apg101 (cd95-fc) | |
| CY1123022T1 (el) | Σταθερες φαρμακευτικες συνθεσεις που περιεχουν σιταγλιπτινη υπο τη μορφη δισκιων αμεσης απελευθερωσης | |
| MX2014005510A (es) | Nuevas composiciones, produccion de las mismas y uso de las mismas para la produccion de poliamidas coladas. | |
| PH12020550703A1 (en) | Sulfonamide compounds and use thereof | |
| TR201901146T4 (tr) | İndigo naturalisten bir ekstrakt ve bunun hazırlanmasına yönelik bir proses. | |
| MX2020002123A (es) | Sales de ribociclib y formas en estado sólido de las mismas. | |
| GB201303865D0 (en) | Pharmaceutical composition and method of inhibiting of production or amplifyingelimination of P24 protein | |
| MX2017015137A (es) | Composicion farmaceutica oral de dosis diaria de isotretinoin. | |
| TR201820050T4 (tr) | Bromodomain inhibitörleri olarak tetrahidrokinolin türevleri. | |
| TR201821042T4 (tr) | Tofogliflozin içeren katı preparasyonlar ve aynısını üretmeye yönelik metot | |
| EA202090913A1 (ru) | Композиция таблеток с модифицированным высвобождением, содержащая мирабегрон | |
| CY1120528T1 (el) | Παραγωγα βενζοφουρανο-2-σουλφοναμιδιου ως τροποποιητες υποδοχεων χημειοκινων | |
| TR201821107A2 (tr) | RİVAROKSABAN İÇEREN BİR KATI FARMASÖTİK BİLEŞİM ve BİLEŞİMİN HAZIRLANIŞI YÖNTEMİ | |
| EA201992168A1 (ru) | Аналоги деутетрабеназина, их получение и применение |